Endocrine Carcinoma — Trials

Endocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 574
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +1.5%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (236)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06305962	177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors	recruiting	Early Phase 1	30	Radiopharm Theranostics, LtdINDUSTRY	1	Feb 19, 2026	clinicaltrials
NCT05620342	Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer	recruiting	Early Phase 1	24	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Feb 5, 2026	clinicaltrials